Mechanisms of Main Pancreatic Duct Dilatation in Pancreatic Neuroendocrine Tumors (PanNETs): Radiopathologic Correlation Abstract #2261

Introduction: Main pancreatic duct (MPD) dilatation, a frequent observation in cases with adenocarcinoma can also be observed in patients with PanNET.
Aim(s): Describe the patho-radiological aspects of PanNET with MPD dilatation.
Materials and methods: From 2006 to 2016 all consecutive patients with proven PanNET and MPD dilatation seen on pre-operative MRI were included. MR images were independently reviewed by two radiologists. Histopathologic analysis included fibrosis quantification, microvessel density [MVD], hypoxia markers, and serotonin expression.
Conference: 15th Annual ENETS conference (2018)
Category: Imaging and Interventions (radiology, endoscopy)
Presenting Author: Dr Jerome Cros

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2258 Cystic Duct Gastrinoma in a Patient with MEN1: A Case Report
Introduction: Gastrinomas are the most common functional enteropancreatic neuroendocrine tumour in MEN1 patients and are located almost exclusively in duodenum. Biliary tree gastrinomas are rare and accounted for 6 cases in literature. Only one of these cases was restricted to the biliary tree without associated duodenal gastrinomas.
Conference: 15th Annual ENETS conference (2018)
Category: Case reports
Presenting Author: MD Eloa Brabo
#998 Intra and Interobserver Reproducibility of CT and MRI for Measurement of Liver Metastasis as a Basis of RECIST Evaluation in Patients with Neuroendocrine Tumors
Introduction: The reliability of RECIST evaluation in patients with NET has not yet been analyzed.
Conference: 11th Annual ENETS Conference (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Julia Arfi Rouche
#1381 [18F]FDG-PET/CT as a Predictive Tool for Response to Chemotherapy and Everolimus Treatment in Patientes with Pancreatic Neuroendocrine Tumour
Introduction: The predictive role of 18F-FDG-PET/CT (FP) in neuroendocrine tumours is debated.
Conference: 13th Annual ENETS conference (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Silvia Ortolani
#159 Detection of cardiac metastases in patients with neuroendocrine tumors: comparison of Ga-68 DOTA-SMS-R PET/CT, cardiac MRI, CT scan and 2D echocardiography
Introduction: Neuroendocrine tumor metastases to the heart have been sparsely reported in literature. There is as of yet no detailed study on the best imaging method for the detection of this rare site of metastases.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Vikas Prasad
Authors: Prasad V, Ali S, Secknus M A, Lauer B, ...
#1352 Outcomes of Cytoreductive Surgery for Well-Differentiated Metastatic Neuroendocrine Tumors in the Setting of Extra-Hepatic Metastases
Introduction: Cytoreduction with extra-hepatic disease for neuroendocrine tumors (NET) remains controversial
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: Hallet Julie
Close
Notice

WARNING – FRAUDULENT WEBSITES

ENETS is aware that its members have been confronted with fake websites, which seem to relate to our congress but have not been commissioned or authorised by us. The websites offer fraudulent hotel reservation services. We therefore strongly recommend that you please only use the official enetsconference.org website when booking your tickets and accommodation. Please be vigilant when it comes to providing your credit card details. 

If you have any questions, please do not hesitate to contact us at info@enets.org.